Crescent Biopharma (CBIO) Other Working Capital Changes (2013 - 2026)
Crescent Biopharma (CBIO) posted quarterly Other Working Capital Changes of $1.0 million for Q2 2026, up 32.77% year-over-year from $763000.0 in Q2 2025, and up 8.11% quarter-over-quarter from $937000.0 in Q1 2026.
Crescent Biopharma (CBIO) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has reported Other Working Capital Changes for 14 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Working Capital Changes rose 32.77% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $5.8 million (up 397.53% YoY), while the FY2025 annual figure was $5.0 million, up 398.7% from the prior year.
- Other Working Capital Changes slipped to -$1.0 million in Q1 2026 per CBIO's latest filing, from $4.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.2 million in Q4 2025 and bottomed at -$348876.0 in Q2 2024.
- Historically, Other Working Capital Changes has averaged $459046.2 across 5 years, with a median of $71848.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes tumbled 455.76% — and 2025, when it jumped 10860.53%.
- Crescent Biopharma's Other Working Capital Changes stood at $4.1 million in 2025, then slumped by 125.37% to -$1.0 million in 2026.
- Business Quant data shows CBIO's Other Working Capital Changes at -$1.0 million in Q1 2026, $4.1 million in Q4 2025, and $46000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Crescent Biopharma | 1.05 Bn | 875.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Jun 30, 2026 | 1.01 Mn |
| Jun 30, 2026 | 1.01 Mn |
| Mar 31, 2026 | 937,000.00 |
| Mar 31, 2026 | 937,000.00 |
| Mar 31, 2026 | 937,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Sep 30, 2025 | -1.26 Mn |
| Sep 30, 2025 | -1.26 Mn |
| Sep 30, 2025 | -1.26 Mn |
| Jun 30, 2025 | 763,000.00 |
| Jun 30, 2025 | 763,000.00 |
| Jun 30, 2025 | 763,000.00 |
| Mar 31, 2025 | 371,000.00 |
| Mar 31, 2025 | 371,000.00 |
| Mar 31, 2025 | 371,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Dec 31, 2024 | 38,000.00 |